U.S. Insurance Stock News

On 27 June 2026, Yelp Inc. (NYSE:YELP) was added to several Russell value and small-cap indices, including the Russell 2000 Value, Russell 3000 Value, Russell 3000E Value, Russell 2000 Value-Defensive, and Russell Small Cap Comp Value benchmarks. These index inclusions can broaden Yelp’s institutional investor exposure, as index-linked funds and value-focused portfolios often adjust holdings to mirror benchmark changes. We’ll now examine how Yelp’s broader presence in Russell value and...

On 27 June 2026, Hope Bancorp, Inc. was removed from several Russell growth indexes, including the Russell 2000 Growth and Russell 3000 Growth benchmarks. This broad index removal can matter to investors because growth-index-tracking funds may adjust their holdings, potentially altering trading patterns and liquidity for Hope Bancorp. We’ll now explore how Hope Bancorp’s removal from multiple Russell growth benchmarks may influence its existing investment narrative and risk profile. The best...

Array Technologies (ARRY) is drawing attention after launching its DuraTrack D2S dual row solar tracker for international markets, with the first commercial installation already underway in Spain in early 2026. See our latest analysis for Array Technologies. Even with the DuraTrack D2S launch and a new shelf registration filing, Array Technologies’ share price has come under pressure, with the 30 day share price return down 21.59% and the 1 year total shareholder return still positive at...

Arbor Realty Trust, Inc. was recently removed from the Russell 2000 Dynamic Index, a move that typically prompts portfolio adjustments by index-tracking funds. This index exit may influence how investors view Arbor Realty Trust’s liquidity and visibility relative to other small-cap real estate finance names. We’ll now examine how Arbor Realty Trust’s removal from the Russell 2000 Dynamic Index could reshape its existing investment narrative. We've uncovered the 9 dividend fortresses yielding...

Recently, Zacks upgraded Signet Jewelers to a Rank #2 (Buy), reflecting analysts’ more optimistic earnings estimates and improved near-term expectations for the jeweler’s performance. This shift in analyst sentiment highlights how changing views on Signet’s earnings power can quickly reshape perceptions of its longer-term business outlook. We’ll now examine how this analyst upgrade, driven by stronger earnings expectations, interacts with Signet’s existing investment narrative and future...

In recent days, Corastone announced a partnership with UMB Fund Services, a UMB Financial subsidiary, to connect UMBFS to Corastone’s private, permissioned distributed ledger network for straight-through processing of alternative investment transactions, with StepStone Group as the first client on the platform. This move highlights UMB’s push to enhance fund administration and transfer agency capabilities through blockchain-style infrastructure, potentially raising efficiency and data...

In late June 2026, MFA Financial, Inc. was added to multiple Russell benchmarks, including the Russell 2000 Growth-Defensive, Russell 2500 Growth, Russell 3000 Growth, Russell 3000E Growth, and the Russell Small Cap Comp Growth indices. This broad inclusion across Russell growth and small-cap indices significantly broadens MFA Financial’s presence in benchmark-driven portfolios, potentially increasing attention from institutional and rules-based investors. Now we’ll examine how MFA...

Chip stocks are back in focus as a rebound in the semiconductor sector lines up with renewed interest in dealmaking and broader technology equities. For investors, this combination of improving sentiment in key sectors and active M&A headlines, including recent wins for Goldman Sachs, creates a fresh backdrop to reassess exposure to larger semiconductor companies. This article looks at 3 stocks from a Semiconductor Stocks screener that appear positively exposed to these news driven catalysts...

Why Qiagen’s latest index move and product news matter for investors Qiagen (NYSE:QGEN) has drawn fresh attention after being added to the Russell 1000 Dynamic Index, shortly after announcing an expanded QIAcuity digital PCR ecosystem targeting life sciences and biopharma workflows. Together, these developments give you two angles to watch at once: index driven visibility on the trading side, and a more extensive product offering in areas like gene expression, residual DNA testing, and...

BrightView Holdings (BV) has moved to extend the maturity of its senior secured term loans from April 2029 to June 2033, and is also lengthening its receivables financing facility to June 2029. See our latest analysis for BrightView Holdings. BrightView Holdings’ recent debt maturity extensions come as the stock trades at $14.27, with a 30-day share price return of 15.45% and a 90-day share price return of 21.03%, yet a 1-year total shareholder return that declined 14.29%. This suggests...

On 27 June 2026, Brixmor Property Group Inc. was removed from the Russell 1000 Dynamic Index, prompting index-tracking funds to adjust their positions. This index removal matters because forced buying and selling by rules-based investors can reshape who owns the stock and how it trades over time. With Brixmor’s exit from the Russell 1000 Dynamic Index now in the past, we’ll explore how this change may influence its investment narrative. The best AI stocks today may lie beyond giants like...

Index removals put TIC Solutions in the spotlight TIC Solutions (TIC) has been removed from several Russell indices, including the Russell 2000, 3000, and 2500 growth and defensive benchmarks. This change can influence both trading flows and investor attention. See our latest analysis for TIC Solutions. TIC Solutions has seen mixed momentum, with the share price up 25.99% over the past 90 days but the year to date share price return down 16.18%, and the 1 year total shareholder return down...

The FDA’s new PreCheck pilot is putting fresh attention on U.S. biopharmaceutical manufacturing stocks, as faster facility reviews could reshape how quickly companies bring complex therapies to market. With select facilities from Eli Lilly, Regeneron and others lined up for accelerated oversight, investors are watching which businesses might gain from quicker approvals, added capacity and stronger onshore supply chains, and which could be left waiting. This article walks through 3 stocks from...

Why the QUELL-CV Trial Matters for BioAge Labs Stock BioAge Labs (BIOA) has moved its lead drug candidate, BGE-102, into the Phase 2 QUELL-CV trial, a randomized, placebo-controlled study targeting cardiovascular risk in adults with obesity and elevated inflammation. The trial plans to enroll about 160 participants over 12 weeks of once daily dosing, testing three oral dose levels against placebo. The primary focus is change in high-sensitivity C-reactive protein, with additional inflammatory...

Ferguson Enterprises (FERG) has been removed from the Russell 1000 Defensive, Value Defensive, and Growth Defensive indices, a shift that can influence index fund positioning, institutional ownership, and short term trading flows. See our latest analysis for Ferguson Enterprises. At a share price of $238.61, Ferguson Enterprises has seen a 5.59% 30 day share price return and 6.04% year to date share price return. Its 1 year total shareholder return of 11.26% and 5 year total shareholder...

Index additions put fresh focus on Resideo Technologies Resideo Technologies (REZI) has been added to several Russell growth indices, including the Russell 2500 Growth and Russell 3000 Growth benchmarks, an event that can influence how index-tracking investors view the stock. See our latest analysis for Resideo Technologies. At a share price of US$30.96, Resideo Technologies has seen shorter term momentum soften, with the 90 day share price return down 8.16% and the year to date share price...

With the Federal Reserve hinting at a possible pause in interest rate hikes, slowing inflation, and mixed signals on consumer spending, the next moves in consumer discretionary stocks could matter more than usual. Some companies may benefit if borrowing costs stabilize and confidence holds, while others could feel pressure if households keep tightening their belts. This article looks at how that backdrop connects to three large consumer-focused stocks from our screener that appear positively...

On 27 June 2026, Selective Insurance Group, Inc. was removed as a constituent from several Russell growth and small‑cap benchmarks, including the Russell 2000 and Russell 3000 Growth indices. This broad index removal matters because it can prompt index‑tracking and benchmarked funds to rebalance, temporarily amplifying trading volumes and liquidity pressures around the stock. Next, we’ll examine how being dropped from multiple Russell growth indices could influence Selective Insurance...

Recently, Savara announced that the US FDA accepted its biologics license application for MOLBREEVI for autoimmune pulmonary alveolar proteinosis, assigning a PDUFA target action date of November 22, while CFO David Lowrance exercised 580,187 stock options and sold 394,528 shares. This regulatory milestone and executive share activity highlight both the advancing path toward a potential first-in-class therapy and how insiders are managing their equity exposure at a key moment for the...

With inflation trends shifting, oil prices easing and central banks weighing their next moves, many investors are looking for income streams that feel steadier than short term market headlines. That is where the Dividend Powerhouses screener comes in, focusing on companies with dividend yields above 5% that are covered, growing and relatively stable. In a world of mixed growth signals from the US, Europe and Asia, reliable cash distributions can be a useful anchor for a portfolio. Below,...

National HealthCare (NYSEAM:NHC) has been added to multiple prominent Russell growth indices. This index inclusion reflects Russell’s latest rebalancing and adjusts National HealthCare’s place in key growth benchmarks. The move may affect how institutional investors view and access the stock. National HealthCare enters these Russell growth indices with a recent share price of $206.54 and a reported 3-year return of 263.5%. The stock has also logged a 95.7% return over the past year and is...

Investors were disappointed with Oracle Corporation's ( NYSE:ORCL ) earnings, despite the strong profit numbers. We...

Political tensions around the proposed Save America Act and questions about US institutional strength are back in focus, and that can rattle even seasoned investors. While headlines debate strongman politics and the resilience of courts, media, and the military, some investors are looking again at US blue-chip defensive stocks that may be better suited to handle sharper mood swings in markets. This article walks through 3 stocks from our US Blue-Chip Defensive Stocks screener that appear...

New economic indicators, tougher transparency rules, and a wave of mergers and expansion plans are putting financial services and exchange related stocks under the spotlight. For investors, this mix of data and regulation can quickly change how certain companies are viewed, especially those tied to market infrastructure, fintech, clearing, and compliance. This article walks through 3 stocks from the Financial Services & Exchanges screener that are closely exposed to the latest news, each...